Patents Issued in January 20, 2004
-
Patent number: 6680044Abstract: The present invention provides chemical reactors and reaction chambers and methods for conducting catalytic chemical reactions having gas phase reactants. In preferred embodiments, these reaction chambers and methods include at least one porous catalyst material that has pore sizes large enough to permit molecular diffusion within the porous catalyst material.Type: GrantFiled: August 16, 2000Date of Patent: January 20, 2004Assignee: Battelle Memorial InstituteInventors: Anna Lee Y. Tonkovich, Yong Wang, Sean P. Fitzgerald, Jennifer L. Marco, Gary L. Roberts, David P. VanderWiel, Robert S. Wegeng
-
Patent number: 6680045Abstract: A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.Type: GrantFiled: April 24, 2001Date of Patent: January 20, 2004Assignee: The Curators of the University of MissouriInventors: Silvia S. Jurisson, Thomas P. Quinn, Michael F. Giblin
-
Patent number: 6680046Abstract: The present invention relates to microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable liquid carrier. The present invention further relates to a method for prophylactic or therapeutic embolization which comprises administering to a mammal an injectable suspension containing the polyvinylalcohol microspheres and a suitable liquid carrier. Finally, the present, invention relates to a process for producing the polyvinylalcbhol microspheres.Type: GrantFiled: October 15, 1999Date of Patent: January 20, 2004Assignee: Biosphere Medical, S.A.Inventor: Egisto Boschetti
-
Patent number: 6680047Abstract: Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.Type: GrantFiled: August 10, 2001Date of Patent: January 20, 2004Assignee: Amersham Health ASInventors: Jo Klaveness, Pål Rongved, Anders Høgset, Helge Tolleshaug, Alan Cuthbertson, Aslak Godal, Lars Hoff, Geir Gogstad, Klaus Bryn, Anne Nævestad, Dagfinn Løvhaug, Halldis Hellebust, Magne Solbakken
-
Patent number: 6680048Abstract: Cellobiose esters and particularly &agr; cellobiose octanonanoate has been found able to structure water-immiscible liquids well, and in particular can produce clear structured emulsions. However, such emulsions tend to lose clarity or structural strength during storage. Deviating from &agr;-cellobiose octanonanoate can result in impaired clarity and/or impaired hardness of emulsion sticks. However, acylated cellobiose which contains acyl substituents of formula —O—CO—R in which R represents an n-octyl residue and the percentage Y of the nonanoate acyl substituent —O—CO—R at the anomeric carbon is at least 60% and the percentage A of &agr; anomer is greater than the anomer and not higher than A=74.5 +0.2Y when Y is up to 92% and not higher than A=161−0.74Y when Y is greater than 92% offers the production of sticks combining structurant stability with product clarity and hardness.Type: GrantFiled: October 17, 2001Date of Patent: January 20, 2004Assignee: Unilever Home & Personal Care USA, a division of Conopco, Inc.Inventors: Lynda Grainger, Kathryn Elizabeth Gransden, Andrew Hopkinson, Adam Jan Kowalski, Nicholas Webb, Michael Stephen White
-
Patent number: 6680049Abstract: A cosmetic composition which provides a semi-permanent, crosslinked film on a keratinous substrate, comprising a film-forming polymer having functional groups capable of cross-linking upon exposure to a cross-linking agent reactive with the functional groups; a cross-linking agent reactive with the functional groups of the film-forming polymer; a dissipatable blocking agent which is operable prior to dissipation, to block the cross-linking agent from cross-linking the functional groups of the film-forming polymer, and which, after dissipation, leaves the cross-linking agent free to cross-link the functional groups of the film-forming polymer.Type: GrantFiled: May 10, 2001Date of Patent: January 20, 2004Assignee: Revlon Consumer Products CorporationInventors: Joseph Frank Calello, Shichiu Kwan, Alexander Lukacs, III, Anjali Abhimanyu Patil, Barbara Ann Wolf, George Harvey Armstrong
-
Patent number: 6680050Abstract: The present invention relates to iodine demand disinfectants. It relates in particular to a process for preparing a polyiodide-resin for use as an iodine demand disinfectant wherein a porous strong base anion exchange resin in a salt form, is contacted with a material capable of donating a member absorbable by the resin so as to convert the resin to the polyiodide-resin. The adsorbable member is selected from the group comprising I2 and polyiodide ion having a valence of −1. The process is characterized in that conversion of the anion exchange resin to the polyiodide-resin is effected at elevated temperature and elevated pressure, the elevated temperature being 100 degrees C. or higher, the elevated pressure being greater than atmospheric pressure. The present invention also relates to disinfectant substance comprising an iodine (impregnated) resin as produced by the above process.Type: GrantFiled: March 12, 1999Date of Patent: January 20, 2004Assignee: Triosyn Holdings, Inc.Inventor: Pierre Jean Messier
-
Patent number: 6680051Abstract: Polymers containing amino acid and/or polypeptide moieties in their backbones or pendant to their backbones are made by metathesis. A method of making an amino acid or polypeptide containing polymer includes the steps of: providing a amino acid, amino alcohol, or polypeptide-containing monomer; forming a reaction mixture by contacting the monomer with an agent capable of catalyzing the polymerization of the monomer into a polymer; and placing the reaction mixture under conditions that result in the formation of the polymer in reaction mixture.Type: GrantFiled: August 20, 2001Date of Patent: January 20, 2004Assignee: University of FloridaInventors: Kenneth B. Wagener, Timothy E. Hopkins, James H. Pawlow, Fernando J. Gomez
-
Patent number: 6680052Abstract: Methods of treating and/or imaging tumors utilize A1 adenosine-receptor activated cells (such as monocytes and macrophages) are described. Activated cells may be administered systemically or locally, and may be radiolabelled to provide imaging and diagnostic functions. Macrophages resident in tissues may be primed and activated for use in treating and imaging tumors.Type: GrantFiled: December 16, 1999Date of Patent: January 20, 2004Assignee: Endacea, Inc.Inventor: Constance Neely
-
Patent number: 6680053Abstract: The present invention relates to a variable region of the monoclonal antibody against the S-surface antigen of hepatis B virus and a gene encoding the same, a recombinant vector containing the said gene, and a transformant obtained from the said recombinant vector.Type: GrantFiled: May 29, 2001Date of Patent: January 20, 2004Assignee: Yuhan CorporationInventors: Jong Wook Lee, In Young Ko, Heui Keun Kang, Jung Hyun Nam, Moo Young Song, Hyung Jin Moon, Tae Hun Song
-
Patent number: 6680054Abstract: The invention provides novel macromolecules, methods for their preparation, pharmaceutical formulations thereof and their use as anti-influenza agents. The invention also provides a novel diagnostic method which can be used for detection of all types of influenza A and B virus. The macromolecular compound of the invention has attached to it one or more molecules (neuraminidase binders) which bind to the active site of influenza virus neuraminidase but which are not cleaved by the neuraminidase.Type: GrantFiled: July 16, 1999Date of Patent: January 20, 2004Assignee: Biota Scientific Management PTY Ltd.Inventors: Phillip A. Reece, Keith Geoffrey Watson, Wen-Yang Wu, Betty Jin, Guy Y. Krippner
-
Patent number: 6680055Abstract: The present invention provides, inter alia, polyketide macrolides including a polyketide macrolide of the structure wherein R1-R5 are the same or different and each is independently selected from the group consisting of hydrogen, R6, a C(O)R7, a C(S)R7, a C(O)NHR7, and a C(S)NHR7, each occurrence of R6 is independently selected from the group consisting of a C1-C6 alkyl, a C5-C12 aryl, and a sugar, each occurrence of R7 is independently selected from the group consisting of hydrogen, a C1-C6 alkyl, and a C5-C12 aryl, and wherein R1 and R2, R2 and R3, and/or R4 and R5 can be taken together to form a ketal ring. Also provided are asceptic mixtures of polyketide macrolides isolated from M.Type: GrantFiled: February 27, 2002Date of Patent: January 20, 2004Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Pamela L. C. Small, Kathleen M. George
-
Patent number: 6680056Abstract: Peptides which satisfy the formula of SEQ ID NO: 10 bind to HLA-Cw*1601 molecules, and stimulate proliferation of cytolytic T cells. Examples of such peptides are those set forth in SEQ ID NOS: 4 and 5.Type: GrantFiled: August 8, 2000Date of Patent: January 20, 2004Assignee: Ludwig Institute for Cancer ResearchInventors: Pierre van der Bruggen, Jean-Pierre Szikora, Pierre Coulie, Claude Wildmann, Pascale Boël, Thierry Boon-Falleur
-
Patent number: 6680057Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.Type: GrantFiled: April 14, 2000Date of Patent: January 20, 2004Assignee: Immunex CorporationInventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
-
Patent number: 6680058Abstract: Amphipathic lytic peptides are ideally suited to use in a ligand/cytotoxin combination to induce sterility or long-term contraception in mammals. The peptides act directly on cell membranes, and need not be internalized. Administering a combination of gonadotropin-releasing hormone (GnRH) (or a GnRH agonist) and a membrane-active lytic peptide produces long-term contraception or sterilization in mammals in vivo. The compounds are relatively small, and are not antigenic. Lysis of gonadotropes has been observed to be very rapid (on the order of ten minutes.) The two components—the ligand and the lytic peptide—may optionally be administered as a fusion peptide, or they may be administered separately, with the ligand administered slightly before the lytic peptide, to activate cells with receptors for the ligand, and thereby make those cells susceptible to lysis by the lytic peptide.Type: GrantFiled: February 22, 2000Date of Patent: January 20, 2004Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical CollegeInventors: Frederick M. Enright, Jesse M. Jaynes, William Hansel, Patricia A. Melrose, Philip H. Elzer
-
Patent number: 6680059Abstract: The present invention relates to compositions and methods for enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans. More particularly, the use of Ribavirin as an adjuvant to a vaccine protocol and compositions having Ribavirin and an antigen are described.Type: GrantFiled: March 22, 2002Date of Patent: January 20, 2004Assignee: Tripep ABInventors: Matti Sällberg, Catharina Hultgren
-
Patent number: 6680060Abstract: A live hepatitis A virus adapted to growth in MRC-5 cells, which HAV is preferably characterized by suitable attenuation for effective vaccine administration to humans and animals without inactivation, methods for adapting HAV to growth in MRC-5, vaccine compositions and method of vaccinating humans against HAV infection.Type: GrantFiled: April 29, 2002Date of Patent: January 20, 2004Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Ann W. Funkhouser, Suzanne U. Emerson, Robert H. Purcell, Eric D'Hondt
-
Patent number: 6680061Abstract: The present invention relates to hydrophilic Eimeria polypeptides, DNA-fragments encoding those peptides, recombinant DNA molecules comprising such DNA-fragments, live recombinant carriers comprising such DNA-fragments or recombinant DNA molecules and host cells comprising such DNA-fragments, recombinant DNA molecules or live recombinant carriers. Furthermore, the invention relates to antibodies against the polypeptides and to coccidiosis vaccines based upon said polypeptides. The invention also relates to methods for the preparation of such antibodies and vaccines, and to methods for the detection of Eimeria parasites and antibodies against Eimeria parasites.Type: GrantFiled: December 27, 2000Date of Patent: January 20, 2004Inventors: Theodorus Cornelis Schaap, Catharina Maria Kuiper, Arnoldus Nicolaas Vermeulen
-
Patent number: 6680062Abstract: The present invention relates to a cosmetic or pharmaceutical composition for topical application to the skin afflicted with rosacea and treated with a retinoid. The composition for treating rosacea comprises an anti-irritating component and several other components for treating rosacea. The other components form a mixture of a salicylic acid, a phytosphingosine, green tea, hinokitiol, gorgonian extract, and polysaccharide. The invention also provides a method for decreasing the irritation on the skin caused by the heightened sensitivity experienced by skin suffering from rosacea. The other components are effective in treating the rosacea condition, but particularly, in treating the telangiectasic symptom of rosacea.Type: GrantFiled: October 5, 2001Date of Patent: January 20, 2004Assignee: Color Access, Inc.Inventors: Neelam Muizzuddin, Kenneth D. Marenus, Daniel H. Maes
-
Patent number: 6680063Abstract: The present invention provides a denatured albumin lamina, useful for repairing lesions on solid visceral organs. The lamina comprises human serum albumin, formed into a thin, pliant sheet and denatured. The denatured lamina can be sterilized and stored until used. As well, it can be impregnated with a variety of bioagents. A method for repairing a lesion on a solid visceral organ includes applying an energy-absorbing proteinaceous material to a lesion site on the solid visceral organ lesion; irradiating the proteinaceous material with energy sufficient to fuse the energy-absorbing material at least partially to the lesion site; applying a biocompatible denatured albumin lamina onto the proteinaceous material on the lesion site; and irradiating the biocompatible albumin lamina and the proteinaceous material with energy sufficient to fuse the biocompatible albumin lamina to the proteinaceous material and/or the lesion site.Type: GrantFiled: October 6, 2000Date of Patent: January 20, 2004Assignee: Providence Health System-OregonInventors: Yasmin Wadia, Scott Alan Prahl
-
Patent number: 6680065Abstract: The present invention relates to shaped articles which release agrochemical active compounds, are used for treatment of woody plants and are employed in a hollow preformed in the woody plant, are of a volume which fills the volume of the hollow to the extent of 10 to 95%, are of a volume which does not increase during the period of use to the extent that the preformed hollow space is filled completely, comprise a) agrochemical active compounds, b) water-insoluble thermoplastically processable polymers, c) water-soluble polymers and d) if appropriate further auxiliaries.Type: GrantFiled: April 24, 2001Date of Patent: January 20, 2004Assignee: Bayer AktiengesellschaftInventors: Wolfgang Podszun, Uwe Priesnitz, Jürgen Hölters, Bodo Rehbold, Rafel Israels
-
Patent number: 6680066Abstract: The present invention relates to a composite material with an improved structure in which is dispersed an active organic compound, and a method for treating effluents, in particular a method for treating photographic effluents. The composite material takes the form of a structured gel comprising an aluminosilicate polymer matrix in the form of fibers in which at least two distinct fibers are interconnected by at least two covalent bonds to form an irreversible chemical gel and, dispersed in the matrix, an active organic compound. The choice of the degree of cross-linking of the matrix makes it possible to control the diffusion of a hydrophilic active organic compound. The invention further concerns a method for preparing such a composite material.Type: GrantFiled: February 5, 2002Date of Patent: January 20, 2004Assignee: Eastman Kodak CompanyInventors: Olivier J. Poncelet, Danielle M. Wettling
-
Patent number: 6680067Abstract: A controlled-release pharmaceutical preparation containing an oil suspension which comprises an analgesic and an injectable oil. The analgesic is either a nalbuphine free base or a pharmaceutical salt of nalbuphine such as nalbuphine HCl. The injectable oil is preferably sesame oil. The oil suspension contains microparticles in the size range of 1 to 100 &mgr;m, preferably less than 50 &mgr;m, which is produced by treating the analgesic and injectable oil in an ultra high energy mixing equipment. The controlled-release preparation permits nalbuphine free base or nalbuphine HCl to have a longer duration of action in relieving pain, and allows the administration of lower doses. A process for preparing the injectable oil suspension is also disclosed.Type: GrantFiled: November 26, 2001Date of Patent: January 20, 2004Inventors: Oliver Yoa-Pu Hu, Cheng-Huei Hsiong
-
Patent number: 6680068Abstract: The invention is based on the discovery that angiogenic vessels have heterogeneous surface charge and that cationic liposomes actually target human tumor blood vessels only in irregularly shaped patches. The invention thus features methods for delivering therapeutic compounds to angiogenic vascular endothelial surfaces using a mixture, or “cocktail”, of positively charged and neutral liposomes. The new methods can be used to target multiple regions on the same tumor vessel and/or clusters of vessels within the same tumor. Liposomes with different chemical and/or physical properties (e.g., charge, stability, solubility, diameter) can be delivered simultaneously, and can target tumor vessels and other angiogenic vessels with greater efficiency compared to cationic liposomes alone.Type: GrantFiled: July 3, 2001Date of Patent: January 20, 2004Assignee: The General Hospital CorporationInventors: Robert B. Campbell, Rakesh K. Jain
-
Patent number: 6680069Abstract: Processes for manufacturing a low-substituted hydroxypropyl cellulose are described that include dipping pulp into an alkaline solution to prepare an alkali cellulose, reacting the alkali cellulose with a hydroxypropylating agent to yield a product in a complete dissolution state, dissolving completely the product in an aqueous medium to provide a product in a complete dissolution state, neutralizing with an acid to yield a precipitate, washing, drying, and pulverizing to yield a powder having a volume-average particle diameter of less than 25 microns which is determined by a dry laser diffraction method, a loose bulk density of 0.29 g/ml or more and less than 0.40 g/ml, and a tapped bulk density of 0.55 g/ml or more. Low-substituted hydroxypropyl celluloses are also described.Type: GrantFiled: November 6, 2000Date of Patent: January 20, 2004Assignee: Shin-Etsu Chemical Co., Ltd.Inventor: Sakae Obara
-
Patent number: 6680070Abstract: The dry blends comprise a powdery or finely-divided active ingredient such as a pharmaceutical, dietary supplement, agricultural chemical, water-treating agent or biocidal agent, and a micronized synthetic polyolefin-based hydrocarbon wax and/or a micronized synthetic polyfluorocarbon wax that is compatible with the active ingredient. Shape-retentive compacted compositions are formed by pressure compacting such blends. Preferred active ingredients are 1,3-dihalo-5,5-dialkylhydantoins and profen pharmaceuticals such as naproxen.Type: GrantFiled: January 18, 2000Date of Patent: January 20, 2004Assignee: Albemarle CorporationInventors: Jonathan N. Howarth, Bruce C. Peters
-
Patent number: 6680071Abstract: This invention relates to a pharmaceutical composition for oral administration comprising a carrier and, as active ingredient, an opioid (&mgr;receptor) agonist, such as fentanyl, or a salt thereof, characterized in that the composition is in the form of a fast-dispersing dosage form designed to release the active ingredient rapidly in the oral cavity. A process for preparing such a composition and the use of such a composition as an analgesic, for the treatment of chronic pain and/or breakthrough pain, as an anesthetic premedication, for the induction of anesthesia, as a sedative and/or for the treatment of anxiety are also provided.Type: GrantFiled: January 14, 2002Date of Patent: January 20, 2004Assignee: R. P. Scherer Technologies, Inc.Inventors: Edward Stewart Johnson, Jon Lacy
-
Patent number: 6680072Abstract: A dry extract is reduced in volume by compacting to produce a solid form of pharmaceutical such as a tablet or capsule containing plant extracts. The particles of compacted matter are subsequently screened to a uniform grain size, masked with titanium dioxide, talc, and highly dispersed silicon dioxide in a first mixing process, and treated with additional adjuvants in two more mixing steps. The masked compacted matter has the flowability required for making tablets and is protected against moisture absorption. The extract portion is a minimum of 65 percent by weight, which allows for producing relatively small tablets that have low disintegration times due to masking.Type: GrantFiled: July 9, 2001Date of Patent: January 20, 2004Assignee: Steigerwald Arzneimitelwerk GmbHInventors: Willi Kuper, Panagiotis Maidonis
-
Patent number: 6680073Abstract: This invention relates to a composition and method for the treatment of white line disease, including ailments such as Onychomycosis, sporotichosis, hoof rot, jungle rot, pseudallecheria boydii, scopulariopsis or athletes foot. The composition of the present invention is useful for the treatment of fungal infections such as Onychomycosis in warm blooded animals such as humans and horses. The method of the present invention is directed to the application of a therapeutic amount of the present composition.Type: GrantFiled: April 10, 2000Date of Patent: January 20, 2004Inventor: Bryon J. Tarbet
-
Patent number: 6680074Abstract: The invention is directed to a composition including propolis, oregano and at least one essential oil and methods of making said composition. The compositions may be applied to the skin and/or mucous membranes and are useful for treating microbial infections including viral infections.Type: GrantFiled: January 19, 2000Date of Patent: January 20, 2004Inventor: Andre Pierre Morice
-
Patent number: 6680075Abstract: Disclosed are a natural invigorating tea and a method for preparing the same. The natural invigorating tea may be in the form of powder, liquid, or granules and is made of parasitic herb, and alder and/or schizandrae fructus, optionally supplemented with torilis fructus and/or polygalae japonica herba. Taking of the tea at least twice a day, morning and evening, invigorates human body.Type: GrantFiled: April 19, 2001Date of Patent: January 20, 2004Inventor: Jong-Hyun Nam
-
Patent number: 6680076Abstract: The present invention relates to natural teas and a method of preparing the same, which is effective in increasing sexual ability or stamina. According to the present invention, there are provided relatively inexpensive natural teas in the form of liquid natural teas, powders, segments, or concentrated extracts, in which Rhodiola sachalinensis, and Cuscutae Semens and/or Torilidis Fructus; Rhodiola sachalinensis and a parasitic plant; or a mixture of all the above herbs is contained as principal elements, to which at least one species selected from the group consisting of Alnus japonica, Salviae Radix, Polyglae Radix, schizandra and lycium is optionally added. Where the natural teas of the present invention are drunk two times one day, an excellent effect of increasing stamina can be obtained.Type: GrantFiled: March 11, 2002Date of Patent: January 20, 2004Inventor: Jong Hyun Nam
-
Patent number: 6680077Abstract: Meat products are produced at high yield without phosphate supplements by using define starter cultures.Type: GrantFiled: February 2, 2001Date of Patent: January 20, 2004Assignee: Kerry Ingredients (UK) LimitedInventors: Susan C. Bailey, Philippe R. Merlin, Evin D. Van Griethuysen
-
Patent number: 6680078Abstract: A method for dispensing a flowable substance, such as a flowable photoresist, on a microelectronic substrate. The method can include dispensing a portion of the flowable substance on the microelectronic substrate, receiving an image of at least some of the flowable substance on the microelectronic substrate, and, (with reference to the image), comparing a characteristic of the image with a pre-selected characteristic, or comparing a time required to dispense the portion of the flowable substance with a pre-selected, or both. The method can further include adjusting a characteristic of the dispense process when the image differs from the pre-selected image by at least a predetermined amount, or when the time differs from the pre-selected time by at least a predetermined amount, or both.Type: GrantFiled: July 11, 2001Date of Patent: January 20, 2004Assignee: Micron Technology, Inc.Inventors: John T. Davlin, Greg Montanino
-
Patent number: 6680079Abstract: A magnetic recording medium is formed with a distribution of servo-marks in the form of pits or indentations with an attendant reduction in potential corrosion and increased tribology. Embodiments providing a protective overcoat, e.g. containing carbon, over a magnetic recording medium having a servo-patterned substrate; applying a fluoropolyether comprising one or more acrylate groups on the protective overcoat by dip coating the magnetic recording medium in a solution of the fluoropolyether and polymerizing the fluoropolyether by ultraviolet radiation.Type: GrantFiled: June 4, 2001Date of Patent: January 20, 2004Assignee: Seagate Technology LLCInventors: Michael Stirniman, Li-Ping Wang, Gary Rauch
-
Patent number: 6680080Abstract: This invention relates to a method of antiglare treatment of an organic or inorganic substrate, particularly, sensitive to temperature increases such as phosphate substrates and to a material having antiglare properties that can be obtained by the method of the invention. The invention method comprises a step of deposition a layer of a fluorinated polymer with a low refractive index onto the substrate from a deposition solution that includes said fluorinated polymer. The invention method can be applied to the manufacture of a pockels cell.Type: GrantFiled: August 31, 2000Date of Patent: January 20, 2004Assignee: Commissariat a l'Energie AtomiqueInventor: Philippe Belleville
-
Patent number: 6680081Abstract: A conductive powder having an organic silicon polymer layer on the surface of each particle and a metal layer enclosing the silicon polymer layer possesses a stronger bond between the particle base and the metal even at elevated temperature and exhibits a high and stable conductivity and heat resistance.Type: GrantFiled: March 22, 2002Date of Patent: January 20, 2004Assignee: Shin-Etsu Chemical Co., Ltd.Inventors: Motoo Fukushima, Kunio Itoh, Shigeru Mori, Masaki Kasashima, Yoshitaka Hamada, Mikio Aramata
-
Patent number: 6680082Abstract: The present invention relates to neutralized copolymer resins having at least two different metals with one of the metals being zinc. These mixed metal resins are transformed into particulate or powder form for application to metal objects. The powder composition has a good balance of properties including all the advantages associated with neutralized ethylene acid copolymers while also having good powder coating behavior for coatings applied to metal objects. The invention also relates to coated metal objects containing the powder composition and metal.Type: GrantFiled: October 3, 2002Date of Patent: January 20, 2004Assignee: E. I. du Pont de Nemours and CompanyInventors: Richard Tien-Hua Chou, Mark Bernard Kelly
-
Patent number: 6680083Abstract: A ceiling design tool and method of using the tool for forming plaster designs on walls and ceilings comprising a circular planar face portion having a centered cylindrical handle. The face portion comprises a rubber layer over a burlap layer clamped onto the edge of a circular metal plate. The face portion of the tool is dipped in a fluid plaster mixture and applied to a ceiling or wall surface of either plaster or drywall in a stepwise rolling motion to create a unique textured surface such as half-moons, bead work and scroll patterns.Type: GrantFiled: April 18, 2002Date of Patent: January 20, 2004Inventors: Robert M. Ray, Linda Seward
-
Patent number: 6680084Abstract: The invention relates to a substrate coated with an oriented multilayer polymeric film comprising at least two layers of polymer particles oriented along two different directions with respect to one another. Such an oriented multilayer polymeric film has improved flexibility as well as improved gas barrier properties. A method of forming the film on a substrate is also disclosed.Type: GrantFiled: June 12, 2000Date of Patent: January 20, 2004Assignee: Simex Technologies Inc.Inventor: Halim Chtourou
-
Patent number: 6680085Abstract: The method for thermal spraying, especially of metals, for the coating of surfaces, wherein the material employed for coating is supplied in the form of a wire, molten and sprayed, uses a plasma arc.Type: GrantFiled: January 9, 2003Date of Patent: January 20, 2004Assignee: Grillo-Werke AGInventor: Dieter Kley
-
Patent number: 6680086Abstract: Method and assembly for forming a paper or board web and a product made using the method. According to the method, the web (11) is made from fibers and then the web (11) is treated with pigment particles. The web is treated with microscopic pigment particles whose average size is so small as to permit the particles to adhere to each other by van der Waals forces. The particles are transferred to the web and adhered thereto advantageously using an ion-blast technique.Type: GrantFiled: April 19, 2001Date of Patent: January 20, 2004Assignee: Mesto Paper OyInventors: Vilho Nissinen, Timo Nyberg, Pasi Rajala, Lars Grönroos, Pentti Virtanen, Veli Käsmä, Hannu Niemelä
-
Patent number: 6680087Abstract: A surface treatment composition of the present invention comprises (A) urethaneacrylate oligomer, (B) acrylate based monomer, (C) photoinitiator, (D) silicon additive, and (E) silica matting agent. The present invention provides a surface treatment composit on in which imparts beneficial properties to urethaneacrylate decorative floor coverings, including urethaneacrylates formed from soft type urethaneacrylate oligomer, hard type urethaneacrylate oligomer a and a mixture of soft type and hard type urethaneacrylate oligomer The stain resistance of a decorative floor covering in which a surface treating sub-layer is formed by UV curing after an above surface treatment composition is coated is excellent.Type: GrantFiled: March 26, 2002Date of Patent: January 20, 2004Assignee: LG Chem, Ltd.Inventors: Ho-Zun Park, Min-Ho Son
-
Patent number: 6680088Abstract: A process for producing a magnetic recording medium is provided in which a magnetic layer including a ferromagnetic powder and a binder is provided on a non-magnetic flexible support. In the process, a magnetic liquid containing mainly a ferromagnetic powder and a binder, and an abrasive liquid paste including an abrasive and a binder are prepared separately, and the abrasive liquid paste is subsequently subjected to an ultrasonic dispersion treatment and then mixed with the magnetic liquid to prepare a magnetic coating solution for the magnetic layer.Type: GrantFiled: May 22, 2002Date of Patent: January 20, 2004Assignee: Fuji Photo Film Co., Ltd.Inventors: Koji Naoe, Hiroyuki Kobayashi
-
Patent number: 6680089Abstract: To provide a thermal transfer sheet which is not affected by the illumination light source even in comparison with the pigment coloring material or printed matter and upon transfer of the coloring material thin film, ensures excellent sharpness of halftone dots, good sensitivity, reduced film fogging and very stable transfer releasability. A thermal transfer sheet comprising a support having provided thereon at least a light-to-heat conversion layer containing a light-to-heat conversion substance, and an image forming layer in this order, wherein the absolute value of the difference in the solubility parameter (SP values) obtained by the Okitsu' method between the binder in the image forming layer and the binder contained in the underlying layer thereof is 1.5 or more.Type: GrantFiled: October 24, 2001Date of Patent: January 20, 2004Assignee: Fuji Photo Film Co., Ltd.Inventors: Kazuhito Miyake, Mitsuru Yamamoto
-
Patent number: 6680090Abstract: A complex profile made of a composite comprising a polyolefin polymer and a wood fiber. The composite is useful in conventional structural applications. The profile can be used in residential and commercial structures. The profile is used in the manufacture of the fenestration components such as windows and doors. The profile is designed with a cross-sectional shape to form structural elements in the fenestration units that possess sufficient strength, thermal stability and weatherability. The member comprises a hollow cross-section with at least one structural web or one fastener web. The profile can have a visible capstock layer and can be assembled using thermal welding processes.Type: GrantFiled: April 3, 2001Date of Patent: January 20, 2004Assignee: Andersen CorporationInventors: Shankar Godavarti, Rodney K. Williams, Michael J. Deaner
-
Patent number: 6680091Abstract: A medicament container for storing a liquid medicament, such as insulin, comprises a wall with at least two opposite portions made of a polymer material having a light transmission at 400 nm of at least 25%, a glass transition temperature above 50° C., and a density of 0.95 g/cm3 or more. The polymer material comprises at least 70% by weight of a copolymer material composed of aliphatic cyclic or bicyclic hydrocarbons with 5 to 7 membered ring or rings and ethylene or propylene. The container is substantially inert to the medicament and, because it is either transparent or at least includes at least two opposed transparent portions, it is possible visually to inspect the contents of the container to make sure that the medicament has not crystalized or polymerized. The walls of the container provide a good barrier against m-cresol/phenol/benzyl alcohol preservatives and water.Type: GrantFiled: December 16, 1997Date of Patent: January 20, 2004Assignee: Novo Nordisk A/SInventors: Thomas Buch-Rasmussen, Patric Jannasch, Erling Bonne Jørgensen
-
Patent number: 6680092Abstract: The invention concerns a method for producing high resolution patterns on a support comprising the following steps: high resolution printing of a varnish on the support; treating the support by electrolysis; washing and drying the support.Type: GrantFiled: May 10, 2002Date of Patent: January 20, 2004Assignee: Cabinet Erman S.A.R.L.Inventor: Michel Levy
-
Patent number: 6680093Abstract: A multilayer composite comprises a layer configuration A/C/B or A/C/B/C/A, wherein I. each layer A comprises a molding composition that comprises at least 50% by weight of a polymer A containing amino groups; II. layer B comprises a molding composition that consists of at least 50% by weight of a thermoplastic polyester or fluoropolymer B; III. each layer C comprises a molding composition that consists essentially of the following components a)-c): a) from 5 to 95 parts by weight of the polymer A, b) from 95 to 5 parts by weight of the polymer B, and c) from 1 to 90 parts by weight of a compatibilizer comprising an alkyl acrylate polymer.Type: GrantFiled: May 15, 1998Date of Patent: January 20, 2004Assignee: Degussa AGInventors: Hans Ries, Michael Schlobohm, Guido Schmitz
-
Patent number: 6680094Abstract: A packaging material having an oxygen-absorbing layer of a thermoplastic resin which is blended with an organic oxidizing component and with a transition metal catalyst, wherein the thermoplastic resin is not substantially oxidized in the presence of the transition metal catalyst. The thermoplastic resin is not deteriorated by oxidation and, hence, oxygen-barrier property is not deteriorated, making it possible to stably suppress the permeation of oxygen over extended periods of time.Type: GrantFiled: December 6, 2001Date of Patent: January 20, 2004Assignee: Toyo Seikan Kaisha, Ltd.Inventors: Atsushi Kikuchi, Ikuo Komatsu, Toshiki Yamada, Yoshihiro Kitano, Go Saito